CenterWatch Interview: Cryoport’s Chief Commercial Officer, Mark W. Sawicki, Ph.D., on a New Era of Logistics Challenges

August 22, 2016

Logistics, and particularly cold chain logistics, has taken an increasingly important role in the development of new therapeutics. With the advent of regenerative medicines and personalized therapies, many advanced cell and gene therapies are extremely sensitive to temperature. Companies that may have once approached logistics as an afterthought are formulating detailed logistics plans factoring in temperature control, time and detailed point-to-point monitoring. In an interview with CenterWatch, Mark W. Sawicki, Ph.D., chief commercial officer of Cryoport, describes the challenges and solutions of cryogenic transport in a new age of therapeutic development. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Temperature Controlled Logistics, Cryoport News, Biopharma Industry News